Navigation Links
SynteractHCR Increasing Participation in Industry Events in US and Europe
Date:8/20/2013

SAN DIEGO, Aug. 20, 2013 /PRNewswire/ -- SynteractHCR, a full-service, global contract research organization (CRO), will attend and present at three conferences in September and October: Outsourcing in Clinical Trials Nordic, Outsourcing in Clinical Trials Southern California and Outsourcing in Clinical Trials New England. Members of SynteractHCR's senior leadership team will present at the conferences.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

Outsourcing in Clinical Trials Nordic will be introduced in Copenhagen, Denmark from September 11-12, to address the expanding biotech in the region. The event is designed to provide a forum for discussing innovative strategies in this growing outsourcing environment. SynteractHCR will exhibit at booth #19. Dr. Francisco Harrison, executive vice president and board member, will serve as the session chairman for day one of the event. Ilari Jauro, director clinical operations, Sweden, will present "Applying Result-driven Techniques to Successfully Transition (and Save) a Failing Study" at 10:00 a.m. CET on Sept. 11th. The presentation will include how to determine when a service provider is not performing and identify when a change in service provider is needed, how to select a new CRO, and how to facilitate a smooth transition that keeps the study on track.

Outsourcing in Clinical Trials Southern California will debut in San Diego on Sept 24-25. The event was designed to support requests in this life science hub. SynteractHCR will exhibit at booth #26. Director of Clinical Technology Services Toby Odenheim, MBA, will give insights on "Electronic Data Capture: The Importance and Impact of Selecting the Optimum EDC Platform for Your Clinical Program." Project Director Barbara Ruby will present "How Doing a Clinical Trial is like Skydiving," which will provide guidelines to establish effective collaboration between CROs and sponsors to achieve optimal working relationships and results.

SynteractHCR will exhibit at booth #55 in the fifth annual event Outsourcing in Clinical Trials New England. Dr. Philip Doren, vice president, biometrics, will present on risk based monitoring at 11:15 a.m. EST on Oct. 1st. Risk-based monitoring has the ability to increase efficiencies of trials by identifying the sources of risk that diminish the objectives of clinical development programs. Dr. Doren will examine how to identify the sources that impose meaningful threats and the actions they might trigger.

SynteractHCR recently introduced its ICD+ platform to leverage the company's deep clinical development expertise, appropriate technology, and optimized execution to drive solution-oriented efficiencies and consistent standards on a global scale. The various programs all speak to elements of this comprehensive methodology and identify ways to take time and cost out of the drug development process.

To set an appointment, contact Matt Smith, SVP business development US at (760) 268-8200.

About SynteractHCR (www.synteracthcr.com)
SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its "Shared Work – Shared Vision" philosophy SynteractHCR provides customized Phase I through IV services collaboratively and cost effectively ensuring on-time delivery of quality data so clients get to decision points faster. Operating in 16 countries, SynteractHCR delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications.

CONTACT:
Erika Couric
Erika@clearpointagency.com
760-230-2424


'/>"/>
SOURCE SynteractHCR
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. SynteractHCR Senior Director of Clinical Operations Mary Clegg Named One of the PharmaVOICE 100 Most Inspiring People in Life Sciences
2. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
3. Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
4. Sangui and SastoMed Complement Licensing Agreement in View of Increasing Sales Success
5. Frost & Sullivan: Modest Growth Projected in the U.S. Breast Imaging Systems Market Amidst Increasing Breast Cancer Prevalence
6. Gastroenterologists Indicate They Are Increasingly Using Biologics to Treat Patients with Crohns Disease in Remission than They Were One Year Ago, According to a Recent BioTrends Report
7. Probiotic Action Shares Insight on What New Foods Are Increasing the Strength of Bad Bacteria
8. Frost & Sullivan Recognizes Sciformixs Continued Growth in the Increasingly Complex Pharmaceutical KPO Market
9. Growing Awareness & Increasing Number of Indications Drive the Global Intravenous Immunoglobulin Market, According to a New Report by Global Industry Analysts, Inc.
10. Report Finds Healthcare Sales Job Openings are Down but Increasing
11. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... VANCOUVER, British Columbia , April 27, 2016 ... "Gesellschaft" oder "NanoStruck") (CSE: NSK) (OTCPink: NSKQB) ( ... sie im Anschluss an ihre Pressemitteilung vom 13. ... Inc. erhalten hat, ihre Finanzen um zusätzliche 200.000.000 ... auf 4.000.000 Kanadische Dollar zu bringen. Davon wurden ...
(Date:4/27/2016)... , ... April 27, 2016 , ... ... is pleased to announce the appointment of John Tilton as Chief Commercial Officer.  ... Director and one of the founding commercial leaders responsible for the commercialization of ...
(Date:4/27/2016)... ... April 27, 2016 , ... ... its Scientific Advisory Board. Dr. Lamka will assist PathSensors in expanding the use ... , PathSensors deploys the CANARY® test platform for the detection of harmful pathogens, ...
(Date:4/27/2016)... ... ... Global Stem Cells Group CEO Benito Novas announced that Duncan Ross, Ph.D. ... Labs in Miami. , In 2004, Ross received his Ph.D. in Immunology from the ... the suppression of graft vs. host disease (GVHD) under UM Professor Robert Levy Ph.D. ...
Breaking Biology Technology:
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
(Date:3/15/2016)... -- --> --> According ... "Digital Door Lock Systems Market - Global Industry Analysis, Size, ... digital door lock systems market in terms of revenue was ... to grow at a CAGR of 31.8% during the period ... (MSMEs) across the world and high industrial activity driving inclusive ...
Breaking Biology News(10 mins):